A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients

NCT01018914 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: Prograf
DRUG: Advagraf
DRUG: Myfortic

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]